CDC and NIH bring COVID-19 self-testing to residents in two locales

CDC and NIH bring COVID-19 self-testing to residents in two locales

NIH will provide the tests (also called a home-test or at-home test) and evaluate the effectiveness of the initiative, which aims to determine if frequent self-administered COVID-19 testing helps residents reduce community transmission of SARS-CoV-2, the virus that causes COVID-19 disease. Regular screening with at-home COVID-19 tests can strengthen our prevention efforts,” said CDC Director Rochelle P. Walensky, M.D., M.P.H. At the same time, publicly available data will be reviewed from other communities of similar size that have not received widespread self-administered tests to evaluate the impact of frequent self-administered testing. The test being supplied through the NIH Rapid Acceleration of Diagnostics (RADxSM) initiativeexternal icon is the QuickVue test developed by San Diego-based diagnostic company Quidel. However, a self-administered rapid test produces confidential results at home in minutes, while laboratory processing takes longer and increases cost.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!